Mergers & Acquisitions ·
Lifecore Biomedical sets Nov 4 special meeting to vote on proposed merger with Lifecore Inc
LFCRLifecore Biomedical, Inc. de
The Board of Directors established November 4, 2026 as the record date for a special stockholder meeting. The meeting will seek approval of the Agreement and Plan of Merger previously entered into on September 27, 2026, with Lifecore Inc. and Hazel Merger Sub, Inc. A preliminary proxy statement will be filed with the SEC to provide further details regarding the transaction. Lifecore Biomedical operates in the medical device industry, specializing in hemostasis and tissue repair solutions.